Ropinirol-Mepha retard 2 mg
Ropinirol-Mepha retard 2 mg is a medicine authorised by Swissmedic under authorisation number 62614. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 June 2013 and the authorisation is valid without a time limit. ATC code N04BC04 places the medicine in the group Anti-Parkinson drugs.
| Authorisation number | 62614 |
|---|---|
| Name | Ropinirol-Mepha retard 2 mg |
| Full name | Ropinirol-Mepha retard 2 mg, Retardtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N04BC04 |
| First authorisation | 18 June 2013 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ropinirol-Mepha retard 2 mg, Retardtabletten | B | 18 June 2013 |
| 2 | Ropinirol-Mepha retard 4 mg, Retardtabletten | B | 18 June 2013 |
| 3 | Ropinirol-Mepha retard 8 mg, Retardtabletten | B | 18 June 2013 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 21 | Tablette(n) | N04BC04 | 01.08.0. | B |
| 2 | 28 | Tablette(n) | N04BC04 | 01.08.0. | B |
| 3 | 28 | Tablette(n) | N04BC04 | 01.08.0. | B |
| 4 | 28 | Tablette(n) | N04BC04 | 01.08.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ropinirol-Mepha retard 2 mg authorised in Switzerland?
Yes. Ropinirol-Mepha retard 2 mg is authorised by Swissmedic under authorisation number 62614, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ropinirol-Mepha retard 2 mg have?
Ropinirol-Mepha retard 2 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ropinirol-Mepha retard 2 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.